Your browser doesn't support javascript.
loading
A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity.
Liu, Lily; Yu, Haijia; Huang, Xin; Tan, Hongzhi; Li, Song; Luo, Yan; Zhang, Li; Jiang, Sumei; Jia, Huifeng; Xiong, Yao; Zhang, Ruliang; Huang, Yi; Chu, Charles C; Tian, Wenzhi.
Afiliação
  • Liu L; Department of Cell Biology, Huabo Biopharm Co Ltd., Shanghai, 201203, China. lily.liu@huabobio.com.
  • Yu H; Department of Cell Biology, Huabo Biopharm Co Ltd., Shanghai, 201203, China. haijia.yu@huabobio.com.
  • Huang X; Department of Antibody Technology, Huabo Biopharm Co Ltd., Shanghai, 201203, China. xin.huang@huabobio.com.
  • Tan H; Department of Protein Science, Huabo Biopharm Co Ltd., Shanghai, 201203, China. hongzhi.tan@huabobio.com.
  • Li S; Department of Antibody Technology, Huabo Biopharm Co Ltd., Shanghai, 201203, China. song.li@huabobio.com.
  • Luo Y; Department of Cell Biology, Huabo Biopharm Co Ltd., Shanghai, 201203, China. yan.luo@huabobio.com.
  • Zhang L; Department of Protein Science, Huabo Biopharm Co Ltd., Shanghai, 201203, China. li.zhang@huabobio.com.
  • Jiang S; Department of Protein Science, Huabo Biopharm Co Ltd., Shanghai, 201203, China. sumei.jiang@huabobio.com.
  • Jia H; Department of Protein Science, Huabo Biopharm Co Ltd., Shanghai, 201203, China. huifeng.jia@huabobio.com.
  • Xiong Y; Department of Protein Science, Huabo Biopharm Co Ltd., Shanghai, 201203, China. yao.xiong@huabobio.com.
  • Zhang R; Department of Project Management, Huabo Biopharm Co Ltd., Shanghai, 201203, China. ruliang.zhang@huabobio.com.
  • Huang Y; Department of Protein Science, Huabo Biopharm Co Ltd., Shanghai, 201203, China. ruliang.zhang@huabobio.com.
  • Chu CC; The Feinstein Institute for Medical Research, North Shore-LIJ Health System, Manhasset, NY, 11030, USA. cchu@nshs.edu.
  • Tian W; Department of Medicine, Hofstra North Shore-LIJ School of Medicine, Hempstead, NY, 11549, USA. cchu@nshs.edu.
BMC Cancer ; 15: 170, 2015 Mar 25.
Article em En | MEDLINE | ID: mdl-25881012
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Fragmentos Fc das Imunoglobulinas / Neoplasias Colorretais / Adenocarcinoma / Neovascularização Fisiológica / Inibidores da Angiogênese / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Neoplasias Pulmonares / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Fragmentos Fc das Imunoglobulinas / Neoplasias Colorretais / Adenocarcinoma / Neovascularização Fisiológica / Inibidores da Angiogênese / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Neoplasias Pulmonares / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China